ascopubs.org: Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer.
Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer.
The American Journal of Managed Care: Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer
Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer
Medical Xpress: AI application in pathology reveals novel insights in endometrial cancer diagnostics
Here are 12 new advances in the battle to beat cancer | World Economic ...
The electrification of mobile construction machinery is also making giant strides towards commercialisation. All of this is driven by advances in lithium-ion battery technology. Looking into the future, long-duration ESSs–which only need recharging weekly, monthly or longer–make off-site recharging from solar or wind farms a real possibility.
The American Journal of Managed Care: FDA Approves Pembrolizumab With Chemotherapy in Advanced Endometrial Carcinoma
The FDA approved pembrolizumab (Keytruda) plus carboplatin and paclitaxel, followed by single-agent pembrolizumab, in adult patients with primary advanced or recurrent endometrial carcinoma. The ...
Optimal surgical debulking to R0 remains a dominant prognostic determinant in ovarian cancer, while PARP inhibitor maintenance has become integral for BRCA-mutant and HRD-positive tumors.
Treatments for advanced endometrial cancer have progressed and improved with the use of immunotherapy with chemotherapy. In November 2021, Stephenie Black-Grant, a 50-year- old artist who lives in ...
“Advanced renal cell carcinoma and advanced endometrial carcinoma are aggressive cancers, and patients urgently need new treatment options that may help improve outcomes,” said Dr. Gregory Lubiniecki, ...